Actinogen Medical Limited (ASX:ACW)
Australia
· Delayed Price · Currency is AUD 0.0400
-0.0010 (-2.44%)
Mar 10, 2026, 10:25 AM AEST
Actinogen Medical Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -17.91 | -14.73 | -13.04 | -10.75 | -9.5 | -3.92 | Upgrade
|
| Depreciation & Amortization | 0.43 | 0.42 | 0.42 | 0.41 | 0.4 | 0.39 | Upgrade
|
| Stock-Based Compensation | 1.66 | 1.66 | 1.31 | 1.52 | 1.29 | 0.29 | Upgrade
|
| Other Operating Activities | -5.68 | 0.01 | -0.02 | -0 | -0.01 | - | Upgrade
|
| Change in Accounts Receivable | 3.5 | 3.5 | -5.2 | -0.18 | -2.41 | 1.49 | Upgrade
|
| Change in Accounts Payable | 1.55 | 1.55 | -0.38 | 0.25 | 0.69 | 0.11 | Upgrade
|
| Change in Other Net Operating Assets | 0.04 | 0.04 | -0.04 | 0.06 | 0.03 | -0.08 | Upgrade
|
| Operating Cash Flow | -16.41 | -7.56 | -16.95 | -8.7 | -9.52 | -1.72 | Upgrade
|
| Capital Expenditures | -0.04 | -0.04 | -0.01 | -0.04 | -0 | -0.01 | Upgrade
|
| Investing Cash Flow | -0.04 | -0.04 | -0.01 | -0.04 | -0 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | 3 | - | - | - | - | Upgrade
|
| Total Debt Issued | 3 | 3 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.06 | -0.09 | -0.08 | -0.07 | -0.08 | Upgrade
|
| Net Debt Issued (Repaid) | -0.21 | 2.94 | -0.09 | -0.08 | -0.07 | -0.08 | Upgrade
|
| Issuance of Common Stock | 0.33 | 12.24 | 19.11 | 0.9 | 13.32 | 10.91 | Upgrade
|
| Other Financing Activities | - | -0.53 | -1.06 | - | -0.83 | -0.72 | Upgrade
|
| Financing Cash Flow | 0.12 | 14.65 | 17.95 | 0.82 | 12.42 | 10.11 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | 0 | 0.01 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0.04 | - | Upgrade
|
| Net Cash Flow | -16.33 | 7.05 | 0.99 | -7.91 | 2.95 | 8.38 | Upgrade
|
| Free Cash Flow | -16.45 | -7.59 | -16.96 | -8.73 | -9.52 | -1.73 | Upgrade
|
| Free Cash Flow Margin | -223.41% | -138.33% | -170.76% | -178.70% | -261.53% | -87.20% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 | -0.00 | Upgrade
|
| Cash Interest Paid | 0.03 | 0.04 | 0.02 | 0.02 | 0.01 | 0.02 | Upgrade
|
| Cash Income Tax Paid | 3.53 | - | - | - | -1.43 | -3.03 | Upgrade
|
| Levered Free Cash Flow | -10.3 | -2.49 | -12.2 | -4.86 | -5.98 | -0.28 | Upgrade
|
| Unlevered Free Cash Flow | -10.19 | -2.46 | -12.18 | -4.85 | -5.97 | -0.26 | Upgrade
|
| Change in Working Capital | 5.08 | 5.08 | -5.62 | 0.13 | -1.69 | 1.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.